Picture of Zydus Lifesciences logo

ZYDUSLIFE — Zydus Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Zydus Lifesciences Receives Final Approval From USFDA For Verapamil Hydrochloride Extended-Release Tablets

Nov 25 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS:

ZYDUS LIFESCIENCES  - RECEIVES FINAL APPROVAL FROM USFDA FOR VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS

Source text: [ID:]

Further company coverage: ZYDU.NS

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zydus Lifesciences

See all news